Company details
About
Atherosclerosis is a chronic inflammatory disease in which the walls of the blood vessels are thickened and become less elastic. During the discovery phase of the collaboration, Dyax will utilize its proprietary antibody libraries to generate fully human monoclonal antibodies.
Number of employees
1 - 10
Main industry
Health Care
Industry tags
Founded in
2005
Headquarters
Stockholm
Country
Sweden
Sign up to uncover company details
5 free credit every month
Employee contacts
Name
Job Title
Phone